Arvinas (ARVN) Depreciation & Amortization (CF) (2017 - 2026)

Arvinas' (ARVN) quarterly Depreciation & Amortization (CF) came in at $700000.0 in Q1 2026, little changed year-on-year from $700000.0 in Q1 2025, and little changed quarter-over-quarter from $700000.0 in Q4 2025.

Arvinas (ARVN) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Arvinas' Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $700000.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) changed 0.0% year-over-year to $700000.0 in Q1 2026; TTM through Mar 2026 was $3.0 million, a 26.83% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 34.78% from the prior year.
  • Depreciation & Amortization (CF) was little changed at $700000.0 in Q1 2026 per ARVN's latest filing, from $700000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.7 million in Q4 2022 and bottomed at $700000.0 in Q1 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $1.2 million (2023), against an average of $1.1 million.
  • Across the five-year window, Depreciation & Amortization (CF) surged 36.36% in 2022 and slumped 41.67% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $1.7 million in 2022, then declined by 29.41% to $1.2 million in 2023, then retreated by 8.33% to $1.1 million in 2024, then plunged by 36.36% to $700000.0 in 2025, then changed by 0.0% to $700000.0 in 2026.
  • Per Business Quant, the three latest ARVN Depreciation & Amortization (CF) figures stand at $700000.0 (Q1 2026), $700000.0 (Q4 2025), and $800000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Arvinas 519.68 Mn -95.22 Mn - 700,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 700,000.00
Mar 31, 2026 700,000.00
Dec 31, 2025 700,000.00
Dec 31, 2025 700,000.00
Sep 30, 2025 800,000.00
Sep 30, 2025 800,000.00
Jun 30, 2025 800,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 700,000.00
Mar 31, 2025 700,000.00
Dec 31, 2024 1.10 Mn
Dec 31, 2024 1.10 Mn
Sep 30, 2024 1.10 Mn
Sep 30, 2024 1.10 Mn
Jun 30, 2024 1.20 Mn
Jun 30, 2024 1.20 Mn
Mar 31, 2024 1.20 Mn
Mar 31, 2024 1.20 Mn
Dec 31, 2023 1.20 Mn
Dec 31, 2023 1.20 Mn